ESC 365 - Similarities and differences between SGLT2i trials in HFpEF

HFA Premium Access

Similarities and differences between SGLT2i trials in HFpEF

Session: What next for trials in heart failure with preserved ejection fraction?

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Professor S. Solomon (Boston, US)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

73 presentations

28 followers

3 more presentations in this session

Do we need trials to account for sex differences in HFpEF?

Speaker: Professor C. Lam (Singapore, SG)

Do we need trials of combination pharmacotherapy?

Speaker: Professor N. Sato (Kawaguchi, JP)

What next for trials in heart failure with preserved ejection fraction? - discussion.

Access the full session

What next for trials in heart failure with preserved ejection fraction?

Speakers: Professor S. Solomon, Professor C. Lam, Professor N. Sato

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources